The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Intracranial Aneurysm Treatment Market Research Report 2025
Synopsis
Intracranial aneurysm, also known as brain or cerebral aneurysm, is a bulging, weakened area in the wall of an artery in the brain. It results in an abnormal ballooning, widening, or bleb. An intracranial aneurysm majorly occurs in an artery located in the front part of the brain, which supplies oxygen-rich blood to the tissues. Factors contributing to the formation of intracranial aneurysm are hypertension, smoking, injury or trauma to the blood vessels, complication from few types of blood infections, and genetic predisposition. The treatment of intracranial aneurysm includes medical therapy, surgical clipping or therapy and endovascular therapy or coiling without or with adjunctive devices.
The global Intracranial Aneurysm Treatment market was valued at US$ 1084.7 million in 2023 and is anticipated to reach US$ 1715.8 million by 2030, witnessing a CAGR of 6.7% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion US$ in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion US$ in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Intracranial Aneurysm Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intracranial Aneurysm Treatment.
Report Scope
The Intracranial Aneurysm Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intracranial Aneurysm Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intracranial Aneurysm Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
Microport Scientific Corporation
B. Braun
Stryker
Johnson and Johnson
Microvention Inc.
Codman Neuro (Integra Lifesciences)
Raumedic AG
Integra Life Sciences Corporation
Segment by Type
Surgical Clipping
Endovascular Coiling
Flow Diverters
Others
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Intracranial Aneurysm Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Intracranial aneurysm, also known as brain or cerebral aneurysm, is a bulging, weakened area in the wall of an artery in the brain. It results in an abnormal ballooning, widening, or bleb. An intracranial aneurysm majorly occurs in an artery located in the front part of the brain, which supplies oxygen-rich blood to the tissues. Factors contributing to the formation of intracranial aneurysm are hypertension, smoking, injury or trauma to the blood vessels, complication from few types of blood infections, and genetic predisposition. The treatment of intracranial aneurysm includes medical therapy, surgical clipping or therapy and endovascular therapy or coiling without or with adjunctive devices.
The global Intracranial Aneurysm Treatment market was valued at US$ 1084.7 million in 2023 and is anticipated to reach US$ 1715.8 million by 2030, witnessing a CAGR of 6.7% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion US$ in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion US$ in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Intracranial Aneurysm Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intracranial Aneurysm Treatment.
Report Scope
The Intracranial Aneurysm Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intracranial Aneurysm Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intracranial Aneurysm Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
Microport Scientific Corporation
B. Braun
Stryker
Johnson and Johnson
Microvention Inc.
Codman Neuro (Integra Lifesciences)
Raumedic AG
Integra Life Sciences Corporation
Segment by Type
Surgical Clipping
Endovascular Coiling
Flow Diverters
Others
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Intracranial Aneurysm Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Intracranial Aneurysm Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Surgical Clipping
1.2.3 Endovascular Coiling
1.2.4 Flow Diverters
1.2.5 Others
1.3 Market by Application
1.3.1 Global Intracranial Aneurysm Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Intracranial Aneurysm Treatment Market Perspective (2019-2030)
2.2 Intracranial Aneurysm Treatment Growth Trends by Region
2.2.1 Global Intracranial Aneurysm Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Intracranial Aneurysm Treatment Historic Market Size by Region (2019-2024)
2.2.3 Intracranial Aneurysm Treatment Forecasted Market Size by Region (2025-2030)
2.3 Intracranial Aneurysm Treatment Market Dynamics
2.3.1 Intracranial Aneurysm Treatment Industry Trends
2.3.2 Intracranial Aneurysm Treatment Market Drivers
2.3.3 Intracranial Aneurysm Treatment Market Challenges
2.3.4 Intracranial Aneurysm Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Intracranial Aneurysm Treatment Players by Revenue
3.1.1 Global Top Intracranial Aneurysm Treatment Players by Revenue (2019-2024)
3.1.2 Global Intracranial Aneurysm Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Intracranial Aneurysm Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Intracranial Aneurysm Treatment Revenue
3.4 Global Intracranial Aneurysm Treatment Market Concentration Ratio
3.4.1 Global Intracranial Aneurysm Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Intracranial Aneurysm Treatment Revenue in 2023
3.5 Intracranial Aneurysm Treatment Key Players Head office and Area Served
3.6 Key Players Intracranial Aneurysm Treatment Product Solution and Service
3.7 Date of Enter into Intracranial Aneurysm Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Intracranial Aneurysm Treatment Breakdown Data by Type
4.1 Global Intracranial Aneurysm Treatment Historic Market Size by Type (2019-2024)
4.2 Global Intracranial Aneurysm Treatment Forecasted Market Size by Type (2025-2030)
5 Intracranial Aneurysm Treatment Breakdown Data by Application
5.1 Global Intracranial Aneurysm Treatment Historic Market Size by Application (2019-2024)
5.2 Global Intracranial Aneurysm Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Intracranial Aneurysm Treatment Market Size (2019-2030)
6.2 North America Intracranial Aneurysm Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Intracranial Aneurysm Treatment Market Size by Country (2019-2024)
6.4 North America Intracranial Aneurysm Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Intracranial Aneurysm Treatment Market Size (2019-2030)
7.2 Europe Intracranial Aneurysm Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Intracranial Aneurysm Treatment Market Size by Country (2019-2024)
7.4 Europe Intracranial Aneurysm Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Intracranial Aneurysm Treatment Market Size (2019-2030)
8.2 Asia-Pacific Intracranial Aneurysm Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Intracranial Aneurysm Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Intracranial Aneurysm Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Intracranial Aneurysm Treatment Market Size (2019-2030)
9.2 Latin America Intracranial Aneurysm Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Intracranial Aneurysm Treatment Market Size by Country (2019-2024)
9.4 Latin America Intracranial Aneurysm Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Intracranial Aneurysm Treatment Market Size (2019-2030)
10.2 Middle East & Africa Intracranial Aneurysm Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Intracranial Aneurysm Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Intracranial Aneurysm Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Detail
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Intracranial Aneurysm Treatment Introduction
11.1.4 Medtronic Revenue in Intracranial Aneurysm Treatment Business (2019-2024)
11.1.5 Medtronic Recent Development
11.2 Microport Scientific Corporation
11.2.1 Microport Scientific Corporation Company Detail
11.2.2 Microport Scientific Corporation Business Overview
11.2.3 Microport Scientific Corporation Intracranial Aneurysm Treatment Introduction
11.2.4 Microport Scientific Corporation Revenue in Intracranial Aneurysm Treatment Business (2019-2024)
11.2.5 Microport Scientific Corporation Recent Development
11.3 B. Braun
11.3.1 B. Braun Company Detail
11.3.2 B. Braun Business Overview
11.3.3 B. Braun Intracranial Aneurysm Treatment Introduction
11.3.4 B. Braun Revenue in Intracranial Aneurysm Treatment Business (2019-2024)
11.3.5 B. Braun Recent Development
11.4 Stryker
11.4.1 Stryker Company Detail
11.4.2 Stryker Business Overview
11.4.3 Stryker Intracranial Aneurysm Treatment Introduction
11.4.4 Stryker Revenue in Intracranial Aneurysm Treatment Business (2019-2024)
11.4.5 Stryker Recent Development
11.5 Johnson and Johnson
11.5.1 Johnson and Johnson Company Detail
11.5.2 Johnson and Johnson Business Overview
11.5.3 Johnson and Johnson Intracranial Aneurysm Treatment Introduction
11.5.4 Johnson and Johnson Revenue in Intracranial Aneurysm Treatment Business (2019-2024)
11.5.5 Johnson and Johnson Recent Development
11.6 Microvention Inc.
11.6.1 Microvention Inc. Company Detail
11.6.2 Microvention Inc. Business Overview
11.6.3 Microvention Inc. Intracranial Aneurysm Treatment Introduction
11.6.4 Microvention Inc. Revenue in Intracranial Aneurysm Treatment Business (2019-2024)
11.6.5 Microvention Inc. Recent Development
11.7 Codman Neuro (Integra Lifesciences)
11.7.1 Codman Neuro (Integra Lifesciences) Company Detail
11.7.2 Codman Neuro (Integra Lifesciences) Business Overview
11.7.3 Codman Neuro (Integra Lifesciences) Intracranial Aneurysm Treatment Introduction
11.7.4 Codman Neuro (Integra Lifesciences) Revenue in Intracranial Aneurysm Treatment Business (2019-2024)
11.7.5 Codman Neuro (Integra Lifesciences) Recent Development
11.8 Raumedic AG
11.8.1 Raumedic AG Company Detail
11.8.2 Raumedic AG Business Overview
11.8.3 Raumedic AG Intracranial Aneurysm Treatment Introduction
11.8.4 Raumedic AG Revenue in Intracranial Aneurysm Treatment Business (2019-2024)
11.8.5 Raumedic AG Recent Development
11.9 Integra Life Sciences Corporation
11.9.1 Integra Life Sciences Corporation Company Detail
11.9.2 Integra Life Sciences Corporation Business Overview
11.9.3 Integra Life Sciences Corporation Intracranial Aneurysm Treatment Introduction
11.9.4 Integra Life Sciences Corporation Revenue in Intracranial Aneurysm Treatment Business (2019-2024)
11.9.5 Integra Life Sciences Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
